Literature DB >> 21209034

Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.

Shumin Yang1, Qifu Li, Li Zhong, Ying Song, Bo Tian, Qingfeng Cheng, Hua Qing, Wei Xia, Mei Luo, Mei Mei.   

Abstract

CONTEXT: Serum pigment epithelium-derived factor (PEDF) is highly expressed in adipose tissue and plays an important role in insulin resistance (IR). However, there are no data on serum PEDF levels and their relationship with IR in polycystic ovary syndrome (PCOS) women.
OBJECTIVE: To quantitate serum PEDF levels and examine their relationship with IR in women with PCOS. PARTICIPANTS AND
DESIGN: Ninety-six PCOS women and 63 healthy age-matched controls were recruited. Ninety-six PCOS women and 20 controls underwent hyperinsulinemic-euglycemic clamp to assess their insulin sensitivity, which was expressed as M value. IR was also estimated by homeostasis model assessment 2 (HOMA2-IR).
SETTING: The study was performed at a clinical research center.
RESULTS: PCOS women had lower M value and higher HOMA2-IR as compared with controls. Serum PEDF levels were much higher in PCOS women than in controls (5.45 ± 1.85 vs. 3.97 ± 0.98 μg/ml, P < 0.01). Spearman correlation analysis showed that in PCOS women, PEDF positively correlated with body mass index, waist circumference, HOMA2-IR, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and systolic blood pressure and negatively correlated with M value and high-density lipoprotein cholesterol. Multiple linear regression analysis revealed that in PCOS women, after adjustment for body mass index, systolic blood pressure, and serum lipids (triglycerides, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol), PEDF was still associated with M value or HOMA2-IR.
CONCLUSIONS: The serum PEDF level is elevated in women with PCOS and is associated with IR. PEDF may play a role in the pathogenesis of IR in PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209034     DOI: 10.1210/jc.2010-2140

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people.

Authors:  Kyle L Sunderland; Jeanie B Tryggestad; Joshua J Wang; April M Teague; Lauren V Pratt; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  J Clin Endocrinol Metab       Date:  2012-08-28       Impact factor: 5.958

2.  Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels.

Authors:  Anja Böhm; Anna-Maria Ordelheide; Jürgen Machann; Martin Heni; Caroline Ketterer; Fausto Machicao; Fritz Schick; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring; Harald Staiger
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

3.  Mutations in SERPINF1 cause osteogenesis imperfecta type VI.

Authors:  Erica P Homan; Frank Rauch; Ingo Grafe; Caressa Lietman; Jennifer A Doll; Brian Dawson; Terry Bertin; Dobrawa Napierala; Roy Morello; Richard Gibbs; Lisa White; Rika Miki; Daniel H Cohn; Susan Crawford; Rose Travers; Francis H Glorieux; Brendan Lee
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

4.  Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.

Authors:  M L Broadhead; C R Dass; P F M Choong
Journal:  Br J Cancer       Date:  2011-10-06       Impact factor: 7.640

5.  Efficacy of continuously administered PEDF-derived synthetic peptides against osteosarcoma growth and metastasis.

Authors:  Matthew L Broadhead; Peter F M Choong; Crispin R Dass
Journal:  J Biomed Biotechnol       Date:  2012-05-30

6.  Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study.

Authors:  Sheila B Lecke; Debora Morsch; Poli M Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2013-08-14       Impact factor: 5.211

7.  Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation.

Authors:  Shumin Yang; Qiong Lv; Ting Luo; Lulu Liu; Rufei Gao; Shumei Chen; Peng Ye; Qingfeng Cheng; Qifu Li
Journal:  Mediators Inflamm       Date:  2013-10-31       Impact factor: 4.711

8.  Serum LBP Is Associated with Insulin Resistance in Women with PCOS.

Authors:  Qibo Zhu; Huang Zhou; Aipin Zhang; Rufei Gao; Shumin Yang; Changhong Zhao; Yue Wang; Jinbo Hu; Richa Goswami; Lilin Gong; Qifu Li
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

Review 9.  Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy.

Authors:  María Liliana Franco-Chuaire; Sandra Ramírez-Clavijo; Lilian Chuaire-Noack
Journal:  Iran J Basic Med Sci       Date:  2015-09       Impact factor: 2.699

Review 10.  Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.

Authors:  Louiza Belkacemi; Shaun Xiaoliu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.